World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
143
Citations
124982
World Ranking
1466
National Ranking
857

Research.com Recognitions

  • 1975 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Larry Norton is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research spans multiple aspects of cancer biology and treatment, with a particular focus on breast cancer and oncology.

The main fields of study for Larry Norton include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

The subfields within these broader disciplines involve:

  • Cancer Research
  • Oncology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Radiology, Nuclear Medicine and Imaging

Larry Norton's primary research topics cover areas such as:

  • Cancer Genomics and Diagnostics
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers
  • HER2/EGFR in Cancer Research
  • Breast Lesions and Carcinomas

The scientist's recent papers include:

  • 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5), 2020, Annals of Oncology
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis, 2020, Nature Genetics
  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials, 2021, The Lancet Oncology
  • 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4), 2021, UNC Libraries
  • Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,800 women from 86 randomised trials, 2023, The Lancet

Frequent co-authors collaborating with Larry Norton include:

  • Mark E. Robson
  • Pedram Razavi
  • Jorge S. Reis-Filho
  • Joseph O. Deasy
  • Sarat Chandarlapaty

Larry Norton has published extensively in several key scientific venues, such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • npj Breast Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries

In 1975, Larry Norton was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS).

Best Publications

  • Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

    Dennis J. Slamon;Brian Leyland-Jones;Steven Shak;Hank Fuchs

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

    Lyndsay Harris;Herbert Fritsche;Robert Mennel;Larry Norton

  • A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

    Paul E. Goss;James N. Ingle;Silvana Martino;Nicholas J. Robert

  • The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial

    Steven R. Cummings;Stephen Eckert;Kathryn A. Krueger;Deborah Grady

  • Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    Marc L. Citron;Donald A. Berry;Constance Cirrincione;Clifford Hudis

  • The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress

    R.K. Portenoy;H.T. Thaler;A.B. Kornblith;J. McCarthy Lepore

  • Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

    J. Baselga;Debasish Tripathy;J. Mendelsohn;S. Baughman

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

    I. Craig Henderson;Donald A. Berry;George D. Demetri;Constance T. Cirrincione

  • Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

    Noah D. Kauff;Jaya M. Satagopan;Mark E. Robson;Lauren Scheuer

  • Tumor self-seeding by circulating cancer cells

    Mi Young Kim;Thordur Oskarsson;Swarnali Acharyya;Don X. Nguyen

  • Recombinant Humanized anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin Against HER2/neu Overexpressing Human Breast Cancer Xenografts

    Jose Baselga;Larry Norton;Joan Albanell;Young Mee Kim

  • Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

    Paul E. Goss;James N. Ingle;Silvana Martino;Nicholas J. Robert

  • Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.

    Rachel B. Hazan;Greg R. Phillips;Rui Fang Qiao;Larry Norton

  • Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

    Kevin S. Hughes;Lauren A. Schnaper;Donald Berry;Constance Cirrincione

  • Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin

    Jose Baselga;D. Pfister;M. R. Cooper;R. Cohen

  • A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

    Swarnali Acharyya;Thordur Oskarsson;Sakari Vanharanta;Srinivas Malladi

  • Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

    Donald A. Berry;Constance Cirrincione;I. Craig Henderson;Marc L. Citron

Frequent Co-Authors

Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Edi Brogi
Edi Brogi Memorial Sloan Kettering Cancer Center
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Mark E. Robson
Mark E. Robson Memorial Sloan Kettering Cancer Center
Eric P. Winer
Eric P. Winer Yale University
Salvatore Piscuoglio
Salvatore Piscuoglio Humanitas University
Kenneth Offit
Kenneth Offit Memorial Sloan Kettering Cancer Center
Charlotte K.Y. Ng
Charlotte K.Y. Ng Humanitas University
Monica Morrow
Monica Morrow Memorial Sloan Kettering Cancer Center
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine goes beyond traditional medical school. Today, many healthcare professionals are advancing their qualifications with flexible, online study options. For those interested in healthcare leadership, an online health management degree offers a foundation in medical administration, policy, and resource management.

For students aiming for top management roles, pursuing the cheapest master's in healthcare administration is a cost-effective way to gain vital business and organizational skills specific to the healthcare sector.

Those seeking a clinical leadership path might consider advanced practice nursing. The best online dnp programs equip nurses for senior clinical and policy roles, allowing for career progression without pausing work.

Pharmacists can also go further with the best online pharmacy school options, which offer flexibility and affordability while preparing graduates for specialized pharmacy careers.

Choosing the right online degree depends on your existing qualifications and long-term career ambitions. These programs provide accessible, high-impact educational pathways across the healthcare landscape.

Best Scientists Citing Larry Norton

Trending Scientists